Refine Search
(88)
(286)
(506)
(531)

Primary Sclerosing Cholangitis - Pipeline Review, H1 2019

  • $2,000
  • February 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Primary Sclerosing Cholangitis - Pipeline Review, H1 2019’, provides an overview of the Primary Sclerosing Cholangitis pipeline landscape.

The report provides comprehensive information on the therapeutics under ...

Colitis - Pipeline Review, H1 2019

  • $2,000
  • February 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Colitis - Pipeline Review, H1 2019’, provides an overview of the Colitis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Colitis, complete with analysi...

Warts - Pipeline Review, H1 2019

  • $2,000
  • February 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Warts - Pipeline Review, H1 2019’, provides an overview of the Warts pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Warts, complete with analysis by s...

Plague - Pipeline Review, H1 2019

  • $2,000
  • February 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Plague - Pipeline Review, H1 2019’, provides an overview of the Plague pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Plague, complete with analysis b...

Ventilator Associated Pneumonia (VAP) - Pipeline Review, H1 2019

  • $2,000
  • February 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Ventilator Associated Pneumonia (VAP) - Pipeline Review, H1 2019’, provides an overview of the Ventilator Associated Pneumonia (VAP) pipeline landscape.

The report provides comprehensive information on the thera...

Hospital Acquired Pneumonia (HAP) - Pipeline Review, H1 2019

  • $2,000
  • February 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hospital Acquired Pneumonia (HAP) - Pipeline Review, H1 2019’, provides an overview of the Hospital Acquired Pneumonia (HAP) pipeline landscape.

The report provides comprehensive information on the therapeutics ...

Erectile Dysfunction - Pipeline Review, H1 2019

  • $2,000
  • February 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Erectile Dysfunction - Pipeline Review, H1 2019’, provides an overview of the Erectile Dysfunction pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Erec...

Male Hypogonadism - Pipeline Review, H1 2019

  • $2,000
  • February 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Male Hypogonadism - Pipeline Review, H1 2019’, provides an overview of the Male Hypogonadism pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Male Hypog...

Sarcopenia - Pipeline Review, H1 2019

  • $2,000
  • February 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Sarcopenia - Pipeline Review, H1 2019’, provides an overview of the Sarcopenia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Sarcopenia, complete wit...

Acute Respiratory Distress Syndrome - Pipeline Review, H1 2019

  • $2,000
  • February 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Acute Respiratory Distress Syndrome - Pipeline Review, H1 2019’, provides an overview of the Acute Respiratory Distress Syndrome pipeline landscape.

The report provides comprehensive information on the therapeut...

Myasthenia Gravis - Pipeline Review, H1 2019

  • $2,000
  • February 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Myasthenia Gravis - Pipeline Review, H1 2019’, provides an overview of the Myasthenia Gravis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Myasthenia...

Amyloidosis - Pipeline Review, H1 2019

  • $2,000
  • February 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Amyloidosis - Pipeline Review, H1 2019’, provides an overview of the Amyloidosis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Amyloidosis, complete ...

Hypotension - Pipeline Review, H1 2019

  • $2,000
  • January 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hypotension - Pipeline Review, H1 2019’, provides an overview of the Hypotension pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hypotension, complete ...

Thromboembolism - Pipeline Review, H1 2019

  • $2,000
  • January 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Thromboembolism - Pipeline Review, H1 2019’, provides an overview of the Thromboembolism pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Thromboembolis...

Left Ventricular Dysfunction - Pipeline Review, H1 2019

  • $2,000
  • January 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Left Ventricular Dysfunction - Pipeline Review, H1 2019’, provides an overview of the Left Ventricular Dysfunction pipeline landscape.

The report provides comprehensive information on the therapeutics under deve...